Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based Innovators – Seeking Alpha
News-Medical.net |
Rounds Report: Crispr Rallied While FDA Developments Could Benefit Gene-Based Innovators
Seeking Alpha Harnessing the power of the CRISPR/Cas9 editing platform (as depicted in figure 2) – a mechanism perfected by bacteria as a defense tactic for millions of years – it's highly favorable that the lead molecule (CTX-001) will post strong results for the … The First “Cell-Free” CRISPR Tech Is Here To Personalize Cancer Treatment New CRISPR tool allows DNA editing outside of the cell 'Cell-free' CRISPR could improve cancer diagnostics, unravel how gene editing works |
